These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8251321)

  • 1. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
    Uyeki TM; Barry FL; Rosenthal SM; Mathias RS
    Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U; Chan JC
    Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N; Monnens LA
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract]   [Full Text] [Related]  

  • 4. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V; Koller DY; Seidl R; Waldhauser F
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic diabetes insipidus. Radiological and clinical features.
    Hartenberg MA; Cory M; Chan JC
    Int J Pediatr Nephrol; 1985; 6(4):281-6. PubMed ID: 4093246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
    Knoers N; Monnens LA
    Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide, amiloride and tolmetin in the treatment of diabetes insipidus of Brattleboro rats.
    Alon U; Wellons MD; Chan JC
    Med Biol; 1985; 63(3):117-22. PubMed ID: 4068772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin and saluretics in nephrogenic diabetes insipidus of early infancy].
    Reimold EW
    Z Kinderheilkd; 1967; 101(1):6-19. PubMed ID: 4301709
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient.
    Konoshita T; Kuroda M; Kawane T; Koni I; Miyamori I; Tofuku Y; Mabuchi H; Takeda R
    Horm Res; 2004; 61(2):63-7. PubMed ID: 14646392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L; Jonkman A; Thomas C
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
    Pattaragarn A; Alon US
    Pediatr Nephrol; 2003 Oct; 18(10):1073-6. PubMed ID: 12883974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital nephrogenic diabetes insipidus. Report of a case.
    Zhang YM; Zhang XX; Li XL
    Chin Med J (Engl); 1985 Oct; 98(10):775-8. PubMed ID: 3938705
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of severe lithium-induced polyuria with amiloride.
    Kosten TR; Forrest JN
    Am J Psychiatry; 1986 Dec; 143(12):1563-8. PubMed ID: 3538913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Pitfalls of a Newborn with Congenital Nephrogenic Diabetes Insipidus.
    Güran Ö; Güven S; Kırmızıbekmez H; Akgün Doğan Ö; Karadeniz Bilgin L
    J Clin Res Pediatr Endocrinol; 2023 Feb; ():. PubMed ID: 36815512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus with fluorosis.
    Greenberg LW; Nelsen CE; Kramer N
    Pediatrics; 1974 Sep; 54(3):320-2. PubMed ID: 4414789
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.
    Rugpolmuang R; Deeb A; Hassan Y; Deekajorndech T; Shotelersuk V; Sahakitrungruang T
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):193-7. PubMed ID: 23950570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R; Brodehl J
    Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.